Klp Kapitalforvaltning As Keros Therapeutics, Inc. Transaction History
Klp Kapitalforvaltning As
- $20.6 Billion
- Q4 2024
A detailed history of Klp Kapitalforvaltning As transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 5,700 shares of KROS stock, worth $57,855. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,700Holding current value
$57,855% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KROS
# of Institutions
172Shares Held
30.7MCall Options Held
62.4KPut Options Held
9K-
Black Rock Inc. New York, NY2.51MShares$25.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.96MShares$19.9 Million0.0% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.52MShares$15.5 Million7.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.51MShares$15.4 Million0.01% of portfolio
-
State Street Corp Boston, MA1.2MShares$12.2 Million0.0% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $261M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...